{"id":463,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"survodutide-glucagon-glp-1-research-status-and-material-identity","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","title":{"rendered":"Status de pesquisa Survodutide: Dual Glucagon\/GLP-1 Biologia, ensaios e identidade material"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Survodutide \u00e9 um agonista duplo do receptor de glucagon e do receptor GLP-1 em desenvolvimento cl\u00ednico. \u201cAgonista duplo\u201d descreve a farmacologia do receptor; n\u00e3o \u00e9 um certificado de estado cl\u00ednico ou prova de que dois materiais com o mesmo nome abreviado s\u00e3o equivalentes.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">O que o registro mostra<\/h2><ul class=\"wp-block-list\"><li>Os resultados da fase 2 e da fase 3 devem ser atribu\u00eddos \u00e0 formula\u00e7\u00e3o e popula\u00e7\u00e3o estudadas.<\/li><li>O artigo 3 da fase 2026 ainda descreve a survodutide como experimental.<\/li><li>Os controles de sequ\u00eancia, contra-\u00edon, pureza, conte\u00fado e impurezas permanecem quest\u00f5es espec\u00edficas do lote.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828.png\" alt=\"Cientista revisando dados de ensaios metab\u00f3licos e duas vias de sinaliza\u00e7\u00e3o de receptores\" class=\"wp-image-457\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustra\u00e7\u00e3o editorial original utilizada para identificar o tema da pesquisa. N\u00e3o representa lote de cat\u00e1logo, medicamento aprovado, resultado de ensaio ou uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">O limite de identidade e evid\u00eancia<\/h2><p class=\"wp-block-paragraph\">O programa da fase 2 estabeleceu um sinal de varia\u00e7\u00e3o de dose, enquanto o SYNCHRONIZE-1 forneceu o primeiro resultado publicado da obesidade da fase 3. Esses registros respondem a quest\u00f5es de desenvolvimento cl\u00ednico. N\u00e3o respondem se um lote de cat\u00e1logo possui a mesma sequ\u00eancia, formula\u00e7\u00e3o, perfil de exposi\u00e7\u00e3o ou controles de fabrica\u00e7\u00e3o.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Perfil do receptor<\/strong><span>Receptor de glucagon + agonismo do receptor GLP-1<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u00c2ncora de evid\u00eancia atual<\/strong><span>SYNCHRONIZE-1, NCT06066515<\/span><\/div><div class=\"pim-evidence-row\"><strong>Limite do cat\u00e1logo<\/strong><span>Nenhuma infer\u00eancia de equival\u00eancia de formula\u00e7\u00e3o experimental<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">O que pertence ao registro material<\/h2><p class=\"wp-block-paragraph\">Para aquisi\u00e7\u00e3o de pesquisa, registre a sequ\u00eancia exata e a forma molecular, o conte\u00fado de pept\u00eddeos, o m\u00e9todo cromatogr\u00e1fico, a confirma\u00e7\u00e3o de massa, as informa\u00e7\u00f5es sobre \u00e1gua e contra-\u00edon e quaisquer requisitos de agrega\u00e7\u00e3o ou impureza. Evite descrever um material de pesquisa como interven\u00e7\u00e3o cl\u00ednica sem v\u00ednculo documental.<\/p><h2 class=\"wp-block-heading\">Regra editorial<\/h2><p class=\"wp-block-paragraph\">Use o nome exato da interven\u00e7\u00e3o, modelo, popula\u00e7\u00e3o e desfecho do registro citado. N\u00e3o converta uma associa\u00e7\u00e3o, mecanismo, resultado animal, registro de medicamento acabado aprovado ou teste anal\u00edtico em uma afirma\u00e7\u00e3o sobre um lote de cat\u00e1logo n\u00e3o relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>Survodutide \u00e9 um agonista duplo do receptor de glucagon e do receptor GLP-1 em desenvolvimento cl\u00ednico. \u201cAgonista duplo\u201d descreve a farmacologia do receptor; n\u00e3o \u00e9 um certificado de estado cl\u00ednico ou prova de que dois materiais com o mesmo nome abreviado s\u00e3o equivalentes.<\/p>","protected":false},"author":1,"featured_media":628,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"365","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Phase 2 and phase 3 records; development and identity review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Survodutide Once Weekly for Adults with Obesity \u2014 SYNCHRONIZE-1\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42253238\/\",\"note\":\"2026 phase 3 primary record; PMID 42253238.\"},{\"title\":\"Survodutide phase 2 obesity trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38330987\/\",\"note\":\"Dose-ranging clinical context; PMID 38330987.\"},{\"title\":\"ClinicalTrials.gov NCT06066515\",\"url\":\"https:\/\/clinicaltrials.gov\/study\/NCT06066515\",\"note\":\"Registry record for SYNCHRONIZE-1.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Survodutide Research Status: Trials &amp; Material Identity<\/title>\n<meta name=\"description\" content=\"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/survodutide-glucagon-glp-1-research-status-and-material-identity\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity\" \/>\n<meta property=\"og:description\" content=\"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/survodutide-glucagon-glp-1-research-status-and-material-identity\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Survodutide Research Status: Dual Glucagon\\\/GLP-1 Biology, Trials and Material Identity\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\"},\"wordCount\":250,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\",\"name\":\"Survodutide Research Status: Trials & Material Identity\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survodutide Research Status: Dual Glucagon\\\/GLP-1 Biology, Trials and Material Identity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/pt-br\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Status de pesquisa Survodutide: ensaios e identidade material","description":"Survodutide \u00e9 um agonista duplo do receptor de glucagon e do receptor GLP-1 em desenvolvimento cl\u00ednico. \u201cAgonista duplo\u201d descreve a farmacologia do receptor; n\u00e3o \u00e9 uma certeza\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","og_locale":"pt_BR","og_type":"article","og_title":"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity","og_description":"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026","og_url":"https:\/\/nhdbio.com\/pt-br\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"},"wordCount":250,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","url":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","name":"Status de pesquisa Survodutide: ensaios e identidade material","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"Survodutide \u00e9 um agonista duplo do receptor de glucagon e do receptor GLP-1 em desenvolvimento cl\u00ednico. \u201cAgonista duplo\u201d descreve a farmacologia do receptor; n\u00e3o \u00e9 uma certeza\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipe T\u00e9cnica NHD","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"A equipe t\u00e9cnica NHD mant\u00e9m documenta\u00e7\u00e3o de cat\u00e1logo de uso em pesquisa e resumos de evid\u00eancias. Os artigos revisados \u200b\u200bvinculam-se a artigos revisados \u200b\u200bpor pares, registros de ensaios e registros regulat\u00f3rios, ret\u00eam resultados nulos e limita\u00e7\u00f5es de estudos e distinguem interven\u00e7\u00f5es publicadas de materiais de cat\u00e1logo. O desenho assistido por AI pode ser usado para estrutura; os links de origem e os limites das evid\u00eancias permanecem vis\u00edveis. Este trabalho n\u00e3o \u00e9 uma revis\u00e3o independente por pares ou aconselhamento m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/pt-br\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/comments?post=463"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/463\/revisions"}],"predecessor-version":[{"id":513,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/463\/revisions\/513"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/628"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/categories?post=463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/tags?post=463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}